全文获取类型
收费全文 | 675篇 |
免费 | 47篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 31篇 |
妇产科学 | 26篇 |
基础医学 | 54篇 |
口腔科学 | 18篇 |
临床医学 | 58篇 |
内科学 | 141篇 |
皮肤病学 | 3篇 |
神经病学 | 44篇 |
特种医学 | 17篇 |
外科学 | 134篇 |
综合类 | 20篇 |
预防医学 | 30篇 |
眼科学 | 5篇 |
药学 | 76篇 |
中国医学 | 1篇 |
肿瘤学 | 52篇 |
出版年
2023年 | 9篇 |
2022年 | 20篇 |
2021年 | 40篇 |
2020年 | 25篇 |
2019年 | 39篇 |
2018年 | 23篇 |
2017年 | 17篇 |
2016年 | 18篇 |
2015年 | 18篇 |
2014年 | 28篇 |
2013年 | 34篇 |
2012年 | 42篇 |
2011年 | 39篇 |
2010年 | 16篇 |
2009年 | 18篇 |
2008年 | 35篇 |
2007年 | 48篇 |
2006年 | 42篇 |
2005年 | 28篇 |
2004年 | 28篇 |
2003年 | 14篇 |
2002年 | 15篇 |
2001年 | 8篇 |
2000年 | 8篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1992年 | 5篇 |
1991年 | 9篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 7篇 |
1987年 | 9篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1982年 | 3篇 |
1979年 | 2篇 |
1975年 | 3篇 |
1974年 | 7篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1971年 | 8篇 |
1968年 | 3篇 |
1965年 | 2篇 |
1964年 | 2篇 |
1959年 | 1篇 |
1957年 | 2篇 |
1956年 | 1篇 |
排序方式: 共有725条查询结果,搜索用时 156 毫秒
31.
32.
33.
Linjawi A Kontogiannea M Halwani F Edwardes M Meterissian S 《Journal of the American College of Surgeons》2004,198(1):83-90
BACKGROUND: The use of adjuvant chemotherapy in early breast carcinoma is controversial, with most advocating its use in high-risk patients as defined by specific clinicopathologic parameters. Both bcl-2 and p53, which play a role in determining tumor growth by their effects on apoptosis and cell proliferation respectively, may serve to delineate this subset more accurately. The purpose of this study was to determine the prognostic value of bcl-2, Bax, and mutant p53 in stage I breast cancer. STUDY DESIGN: A total of 75 patients with stage Ic breast carcinoma diagnosed from 1989 to 1992 were identified retrospectively and clinicopathologic parameters such as age, tumor size, estrogen receptor (ER) and progesterone receptor (PR) status, disease-free survival and overall survival obtained. Paraffin-embedded formalin-fixed tissues were immunostained with bcl-2, Bax and p53 monoclonal antibodies using a standard avidin biotin peroxidase reaction. Stained slides were evaluated by two independent pathologists for staining intensity and percentage of cells staining positively. Cox regression was used for multivariate survival analysis using the clinicopathologic parameters and molecular markers. Chi-square tests were used for frequency tables. RESULTS: Mean patient age was 58 years (range 29 to 79 years) with a median followup of 80 months from time of diagnosis. The most common histopathology was infiltrating ductal carcinoma. Neither bcl-2 nor Bax expression was associated statistically with disease-free or overall survival. Expression of mutant p53 was associated with a significant decrease in both 5-year disease-free survival (70% versus 98%, p = 0.01 in multivariate analysis) and 5-year overall survival (74% versus 100%, p = 0.03). Expression of bcl-2 was associated with hormone receptor expression and tumor diploid status. Of tumors expressing bcl-2, 36 of 49 (73%) were ER+ (p = 0.017, versus tumors not expressing bcl-2, 6 of 15 [40%]), 22 of 49 (45%) PR+ (p = 0.027 versus tumors not expressing bcl-2, 2 of 15 [13%]) and 28 of 44 (64%) diploid (p = 0.004 versus tumors not expressing bcl-2, 1 of 9 [11%]). CONCLUSIONS: These results indicate that bcl-2 expression is significantly associated with hormonal receptor status and that p53 is a significant prognostic marker for survival in early breast cancer. 相似文献
34.
35.
Tonsillectomy in adults is associated with significant postoperative pain. Intravenous paracetamol injection (Perfalgan) is
marketed for the management of acute pain. This prospective placebo-controlled study was performed to evaluate the analgesic
efficacy and safety of intravenous paracetamol in 76 adult patients undergoing elective standard bipolar diathermy tonsillectomy.
After tonsillectomy was performed under general anesthesia, the patients were randomized to receive either intravenous paracetamol
1 g (Perfalgan) (n = 38) or 0.9% normal saline as a placebo (n = 38) at 6-h intervals. No other analgesic medication was permitted for postoperative pain during the study. Need for rescue
analgesic during the first 24 h after surgery as well as all adverse events were recorded. The intravenous paracetamol group
differed significantly from the placebo group regarding pain relief and median time to pethidine rescue. Intravenous paracetamol
significantly reduced pethidine consumption over the 24-h period. The worst pain after surgery was also more severe in the
placebo group than that in the paracetamol group. There was no significant difference between groups in the incidence of adverse
events. Intravenous paracetamol administered regularly in adult patients with moderate to severe pain after tonsillectomy
provided rapid and effective analgesia and was well tolerated. 相似文献
36.
37.
Propranolol hydrochloride, a water-soluble drug, was incorporated in three transdermal delivery systems using three polymers (hydroxypropylmethylcellulose, polyisobutylene and Ucecryl MC808). The influence of different factors (polymeric material, matrix thickness, drug content, thickness of the adhesive layer and presence of a dissolution enhancer) was investigated. Microscopic observations and DSC thermograms have permitted to demonstrate that propranolol was essentially dissolved in the HPMC matrix and dispersed in the two other matrix types. In vitro dissolution study was carried out according to European Pharmacopoeia. Release from HPMC matrices without adhesive coating was fast. Release from these matrices became more regular (reduction of the burst effect) and slow when they are coated with a 12 microm thick Ucecryl layer. Release from different PIB matrices was too slow to be suitable as TDDS for propranolol. The best release modulation was obtained from Ucecryl matrices. In all matrices types, propylene glycol accelerated propranolol release rate. The kinetic of drug release from most matrix types was more closely described by the square-root model (Higuchi). 相似文献
38.
39.
40.